Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study to Assess the Safety and Efficacy of IQP-PO-101 in Regulating Bowel Movement Frequency

NCT01809587 is registered in ClinicalTrials.gov with InQpharm Group as lead sponsor.

NCT NCT01809587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01809587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study to Assess the Safety and Efficacy of IQP-PO-101 in Regulating Bowel Movement Frequency
Lead sponsor
InQpharm Group
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2013
Completion date
August 31, 2013
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation, irregular bowel movement frequency